Log in

Maryland Chapter 21 of Association of Certified Fraud Examiners

Novartis Pharmaceuticals to Pay $4.4 Million to Resolve Medicaid Fraud Allegations Settles Allegations that Pharmaceutical Company Engaged in Kickback

05 Aug 2020 10:31 PM | Anonymous

Maryland will receive more than $4.4 million to resolve allegations that Novartis Pharmaceuticals Corporation (Novartis) paid kickbacks to health care practitioners in the form of cash, meals, entertainment, and honoraria payments to induce them to prescribe various medications that treat hypertension or Type 2 Diabetes.This is not the first time a pharmaceutical company has paid kickbacks to doctors,. This settlement should be a clear message to drug manufacturers. We are watching, and we will pursue those who attempt to defraud our state,” said Maryland Attorney General Brian Frosh...Novartis admitted to aspects of the scheme in a stipulation filed in federal court in connection with the settlement...Under the settlement, Novartis agreed to pay $678 million to the United States, Maryland, 26 other states, and the District of Columbia, $103 million of which resolves claims pertaining to state Medicaid programs. Maryland’s $4.4 million share of the settlement resolves claims relating specifically to Maryland’s Medicaid program.  Source: Maryland Attorney General

Maryland Chapter 21 of Association of Certified Fraud Examiners

Copyright 2019 ACFEMD. All Rights Reserved. Site by SPARKS!

Powered by Wild Apricot Membership Software